Alvin Wong
Chief Tech/Sci/R&D Officer bei PUMA BIOTECHNOLOGY, INC.
Vermögen: 748 577 $ am 31.03.2024
Profil
Alvin F.
Wong is currently the Chief Scientific Officer at Puma Biotechnology, Inc. He previously worked as the Senior Director-Clinical Development at Proteolix, Inc. from 2007 to 2013.
Prior to that, he served as a Clinical Professor at UCSF School of Pharmacy from 1976 to 1996.
Dr. Wong holds a graduate degree from The University of California, San Francisco.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
0,29% | 12.02.2024 | 141 241 ( 0,29% ) | 748 577 $ | 31.03.2024 |
Aktive Positionen von Alvin Wong
| Unternehmen | Position | Beginn |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01.08.2017 |
Ehemalige bekannte Positionen von Alvin Wong
| Unternehmen | Position | Ende |
|---|---|---|
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 01.01.2013 |
| UCSF School of Pharmacy | Corporate Officer/Principal | 01.01.1996 |
Ausbildung von Alvin Wong
| The University of California, San Francisco | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
